Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 17, 2017

Real-World Palbociclib Dosing Patterns and Associated Impact on Treatment Costs for HR+/HER2− Metastatic Breast Cancer

Expert Opinion on Pharmacotherapy

 

Additional Info

Disclosure statements are available on the authors' profiles:

Expert Opinion on Pharmacotherapy
Real-World Palbociclib Dosing Patterns and Implications for Drug Costs in the Treatment of HR+/HER2- Metastatic Breast Cancer
Expert Opin Pharmacother 2017 Aug 01;18(12)1167-1178, N Li, EX Du, L Chu, M Peeples, J Xie, V Barghout, DH Tang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading